AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 265: R726-R732, 1993;
0363-6119/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubey, R. K.
Right arrow Articles by Kotchen, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubey, R. K.
Right arrow Articles by Kotchen, T. A.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 265, Issue 4 726-R732, Copyright © 1993 by American Physiological Society


ARTICLES

Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats

R. K. Dubey, H. Y. Zhang, S. R. Reddy, M. A. Boegehold and T. A. Kotchen
Department of Medicine, School of Medicine, West Virginia University, Morgantown 26506.

Hypertension is frequently associated with insulin resistance. We evaluated the effects of pioglitazone, an agent that increases insulin sensitivity, on the development of hypertension in the Dahl salt-sensitive (Dahl-S) rat and in the one-kidney, one-clip Sprague-Dawley rat. We also evaluated the effects of pioglitazone on growth of cultured preglomerular renal arteriolar smooth muscle cells. In Dahl-S rats fed a 3% NaCl diet, tail systolic blood pressures and direct arterial pressures were lower (P < 0.05) in pioglitazone-treated (20 mg/kg daily by gavage for 3 wk) than in control rats (n = 10 rats/group). In one-kidney, one-clip Sprague-Dawley rats, systolic blood pressures were also lower in pioglitazone-treated animals (P < 0.0001). In vitro, proliferation of arteriolar smooth muscle cells was stimulated (P < 0.01) by insulin, epidermal growth factor (EGF), and fetal calf serum (FCS); pioglitazone (5 microM) reversibly inhibited (P < 0.01) insulin-, EGF-, and FCS-induced proliferation. Pioglitazone (0.01-100 microM) also inhibited insulin- (1 mU/ml), EGF- (100 ng/ml), and 5% FCS-induced [3H]thymidine incorporation in a concentration-dependent manner (P < 0.01). Thus pioglitazone attenuated the development of hypertension in the Dahl-S rat and the one-kidney, one-clip rat. The ability of pioglitazone to inhibit growth of vascular smooth muscle may contribute to its hypotensive effect.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Bivol, M. Hultstrom, O. A. Gudbrandsen, R. K. Berge, and B. M. Iversen
Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1866 - R1873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Crossno Jr., C. V. Garat, J. E. B. Reusch, K. G. Morris, E. C. Dempsey, I. F. McMurtry, K. R. Stenmark, and D. J. Klemm
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L885 - L897.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. K. Rehan, Y. Wang, S. Sugano, J. Santos, S. Patel, R. Sakurai, L. W. Boros, W.-P. Lee, and J. S. Torday
In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L323 - L333.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Yamamoto, R. Ohki, R. T. Lee, U. Ikeda, and K. Shimada
Peroxisome Proliferator-Activated Receptor {gamma} Activators Inhibit Cardiac Hypertrophy in Cardiac Myocytes
Circulation, October 2, 2001; 104(14): 1670 - 1675.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Aizawa, J.-i. Kawabe, N. Hasebe, N. Takehara, and K. Kikuchi
Pioglitazone Enhances Cytokine-Induced Apoptosis in Vascular Smooth Muscle Cells and Reduces Intimal Hyperplasia
Circulation, July 24, 2001; 104(4): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
W. A. Hsueh, S. Jackson, and R. E. Law
Control of Vascular Cell Proliferation and Migration by PPAR-{gamma}: A new approach to the macrovascular complications of diabetes
Diabetes Care, February 1, 2001; 24(2): 392 - 397.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Takeda, T. Ichiki, T. Tokunou, Y. Funakoshi, N. Iino, K. Hirano, H. Kanaide, and A. Takeshita
Peroxisome Proliferator-Activated Receptor {gamma} Activators Downregulate Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
Circulation, October 10, 2000; 102(15): 1834 - 1839.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. H. Sung, J. L. Izzo Jr, P. Dandona, and M. F. Wilson
Vasodilatory Effects of Troglitazone Improve Blood Pressure at Rest and During Mental Stress in Type 2 Diabetes Mellitus
Hypertension, July 1, 1999; 34(1): 83 - 88.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Hattori, S. Hattori, and K. Kasai
Troglitazone Upregulates Nitric Oxide Synthesis in Vascular Smooth Muscle Cells
Hypertension, April 1, 1999; 33(4): 943 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Moore, M. A. Maher, W. J. Banz, and M. B. Zemel
Chromium Picolinate Modulates Rat Vascular Smooth Muscle Cell Intracellular Calcium Metabolism
J. Nutr., February 1, 1998; 128(2): 180 - 184.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. A. Kotchen
Attenuation of Hypertension by Insulin-Sensitizing Agents
Hypertension, August 1, 1996; 28(2): 219 - 223.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online